Bonovas, S. ., Lytras, T. ., Nikolopoulos, G. ., Peyrin-Biroulet, L. ., & Danese, S. . (2018). Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors’ reply. Alimentary Pharmacology & Therapeutics, 47(4), 540-541. https://doi.org/10.1111/apt.14486

Allocca, M. ., Gilardi, D. ., Fiorino, G. ., Furfaro, F. ., Peyrin-Biroulet, L. ., & Danese, S. . (2018). Sexual and reproductive issues and inflammatory bowel disease: a neglected topic in men. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/MEG.0000000000001074 (Original work published 2018)

Olivera, P. ., Sandborn, W. ., Panés, J. ., Baumann, C. ., D’Haens, G. ., Vermeire, S. ., … Peyrin-Biroulet, L. . (2018). Physicians’ perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.14514 (Original work published 2018)

Gabbiadini, R. ., Zacharopoulou, E. ., Furfaro, F. ., , Zilli, A. ., Gilardi, D. ., … Allocca, M. . Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality?. Current Drug Targets, 22(3), 347-355. https://doi.org/10.2174/1389450121666201119142919 (Original work published 2021)